TAp63α mediates chemotherapeutic agent-induced apoptosis in human bone marrow mesenchymal stem cells

Stem Cells and Development

Volumn 20, Issue 8, 2011, Pages 1319-1326

  Lu, Chunhua ^a   Lu, Shan ^a   Liang, Wei ^b   Li, Jing ^a   Dou, Xiaowei ^a   Bian, Chunjing ^a   Shi, Dan ^a   Liao, Lianming ^a   Zhao, Robert Chunhua ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CISPLATIN; ETOPOSIDE; MITOMYCIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; PROTEIN P63; PROTEIN P63ALPHA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA DAMAGE; DOWN REGULATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; RNA INTERFERENCE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BONE MARROW CELLS; CASPASE 3; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CISPLATIN; ETOPOSIDE; HUMANS; MESENCHYMAL STEM CELLS; POLY(ADP-RIBOSE) POLYMERASES; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 80051487927     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2010.0329     Document Type: Article

References (41)

1. Johnstone B, TM Hering, AI Caplan, VM Goldberg and JU Yoo. (1998). In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res 238:265-272. (Pubitemid 28366150)
2. Ferrari G, G Cusella-De Angelis, M Coletta, E Paolucci, A Stornaiuolo, G Cossu and F Mavilio. (1998). Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279:1528-1530. (Pubitemid 28217075)
3. Jaiswal RK, N Jaiswal, SP Bruder, G Mbalaviele, DR Marshak and MF Pittenger. (2000). Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase. J Biol Chem 275:9645-9652. (Pubitemid 30185197)
4. Hong SH, EJ Gang, JA Jeong, C Ahn, SH Hwang, IH Yang, HK Park, H Han and H Kim. (2005). In vitro differentiation of human umbilical cord blood-derived mesenchymal stem cells into hepatocyte-like cells. Biochem Biophys Res Commun 330:1153-1161.
5. Uetsuki H, H Tsunemori, R Taoka, R Haba, M Ishikawa and Y Kakehi. (2005). Expression of a novel biomarker, EPCA, in adenocarcinomas and precancerous lesions in the prostate. J Urol 174:514-518. (Pubitemid 40981588)
6. Le Blanc K, I Rasmusson, B Sundberg, C Gotherstrom, M Hassan, M Uzunel and O Ringden. (2004). Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363:1439-1441. (Pubitemid 38586721)
7. Aggarwal S and MF Pittenger. (2005). Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105:1815-1822. (Pubitemid 40223708)
8. Horwitz EM, DJ Prockop, LA Fitzpatrick, WW Koo, PL Gordon, M Neel, M Sussman, P Orchard, JCMarx, RE Pyeritz and MK Brenner. (1999). Transplantability and therapeutic effects of bonemarrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 5:309-313. (Pubitemid 29124367)
9. Dasari VR, DG Spomar, C Cady, M Gujrati, JS Rao and DH Dinh. (2007). Mesenchymal stem cells from rat bone marrow downregulate caspase-3-mediated apoptotic pathway after spinal cord injury in rats. Neurochem Res 32:2080-2093. (Pubitemid 350059852)
10. Studeny M, FC Marini, JL Dembinski, C Zompetta, M Cabreira-Hansen, BN Bekele, RE Champlin and M Andreeff. (2004). Mesenchymal stem cells: Potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst 96:1593-1603. (Pubitemid 39534883)
11. Sasportas LS, R Kasmieh, HWakimoto, S Hingtgen, JA van de Water, G Mohapatra, JL Figueiredo, RL Martuza, R Weissleder and K Shah. (2009). Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy. Proc Natl Acad Sci U S A 106:4822-4827.
12. Li J, HK Law, YL Lau and GC Chan. (2004). Differential damage and recovery of human mesenchymal stem cells after exposure to chemotherapeutic agents. Br J Haematol 127:326-334. (Pubitemid 39468948)
13. Mueller LP, J Luetzkendorf, T Mueller, K Reichelt, H Simon and HJ Schmoll. (2006). Presence of mesenchymal stem cells in human bone marrow after exposure to chemotherapy: Evidence of resistance to apoptosis induction. Stem Cells 24:2753-2765. (Pubitemid 46053013)
14. Zhu W, J Chen, X Cong, S Hu and X Chen. (2006). Hypoxia and serum deprivation-induced apoptosis in mesenchymal stem cells. Stem Cells 24:416-425. (Pubitemid 44464811)
15. Levine AJ. (1997). p53, the cellular gatekeeper for growth and division. Cell 88:323-331. (Pubitemid 27131374)
16. Haupt Y. (2004). p53 Regulation: A family affair. Cell Cycle 3:884-885.
17. Yu J and L Zhang. (2005). The transcriptional targets of p53 in apoptosis control. Biochem Biophys Res Commun 331:851-858. (Pubitemid 40615516)
18. Yang A, M Kaghad, Y Wang, E Gillett, MD Fleming, V Dotsch, NC Andrews, D Caput and F McKeon. (1998). p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 2:305-316. (Pubitemid 128379271)
19. Di Como CJ, MJ Urist, I Babayan, M Drobnjak, CV Hedvat, J Teruya-Feldstein, K Pohar, A Hoos and C Cordon-Cardo. (2002). p63 expression profiles in human normal and tumor tissues. Clin Cancer Res 8:494-501. (Pubitemid 34193969)
20. Ogawa E, R Okuyama, S Ikawa, H Nagoshi, T Egawa, A Kurihara, M Yabuki, H Tagami, M Obinata and S Aiba. (2008). p51/p63 Inhibits ultraviolet B-induced apoptosis via Akt activation. Oncogene 27:848-856. (Pubitemid 351186320)
21. Truong AB, M Kretz, TW Ridky, R Kimmel and PA Khavari. (2006). p63 regulates proliferation and differentiation of developmentally mature keratinocytes. Genes Dev 20:3185-3197. (Pubitemid 44790632)
22. Livera G, B Petre-Lazar, MJ Guerquin, E Trautmann, H Coffigny and R Habert. (2008). p63 null mutation protects mouse oocytes from radio-induced apoptosis. Reproduction 135:3-12.
23. Petre-Lazar B, SG Moreno, G Livera, C Duquenne, R Habert and H Coffigny. (2006). p63 expression pattern in foetal and neonatal gonocytes after irradiation and role in the resulting apoptosis by using p63 knockout mice. Int J Radiat Biol 82:771-780. (Pubitemid 44920126)
24. Gressner O, T Schilling, K Lorenz, E Schulze Schleithoff, A Koch, H Schulze-Bergkamen, AM Lena, E Candi, A Terrinoni, MV Catani, M Oren, G Melino, PH Krammer, W Stremmel and M Muller. (2005). TAp63alpha induces apoptosis by activating signaling via death receptors and mitochondria. Embo J 24:2458-2471. (Pubitemid 41032596)
25. Petitjean A, C Cavard, H Shi, V Tribollet, P Hainaut and C Caron de Fromentel. (2005). The expression of TA and DeltaNp63 are regulated by different mechanisms in liver cells. Oncogene 24:512-519. (Pubitemid 40188598)
26. Flores ER, KY Tsai, D Crowley, S Sengupta, A Yang, F McKeon and T Jacks. (2002). p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature 416:560-564. (Pubitemid 34288861)
27. Shi M, J Li, L Liao, B Chen, B Li, L Chen, H Jia and RC Zhao. (2007). Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment: Role in homing efficiency in NOD/SCID mice. Haematologica 92:897-904. (Pubitemid 350144236)
28. Cao Y, Z Sun, L Liao, Y Meng, Q Han and RC Zhao. (2005). Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo. Biochem Biophys Res Commun 332:370-379. (Pubitemid 40724988)
29. Rodriguez R, R Rubio, M Masip, P Catalina, A Nieto, T de la Cueva, M Arriero, N San Martin, E de la Cueva, D Balomenos, P Menendez and J Garcia-Castro. (2009). Loss of p53 induces tumorigenesis in p21-deficient mesenchymal stem cells. Neoplasia 11:397-407.
30. Liang W, C Lu, J Li, JQ Yin and RC Zhao. p73alpha regulates the sensitivity of bone marrow mesenchymal stem cells to DNA damage agents. Toxicology 270:45-56.
31. Mills AA, B Zheng, XJ Wang, H Vogel, DR Roop and A Bradley. (1999). p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398:708-713. (Pubitemid 29197649)
32. Thottassery JV, L Westbrook, H Someya and WB Parker. (2006). c-Abl-independent p73 stabilization during gemcitabine-or 4'-thio-beta-D- arabinofuranosylcytosine-induced apoptosis in wild-type and p53-null colorectal cancer cells. Mol Cancer Ther 5:400-410.
33. Gong JG, A Costanzo, HQ Yang, G Melino, WG Kaelin Jr., M Levrero and JY Wang. (1999). The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature 399:806-809. (Pubitemid 29293179)
34. Suenaga Y, T Ozaki, Y Tanaka, Y Bu, T Kamijo, T Tokuhisa, A Nakagawara and TA Tamura. (2009). TATA-binding Protein (TBP)-like protein is engaged in etoposide-induced apoptosis through transcriptional activation of human TAp63 gene. J Biol Chem 284:35433-35440.
35. Sayan BS, AL Yang, F Conforti, S Bernardini, P Tucci, M Vasa-Nicotera, RA Knight and G Melino. Induction of TAp63 by histone deacetylase inhibitors. Biochem Biophys Res Commun 391:1748-1751.
36. Gonfloni S, L Di Tella, S Caldarola, SM Cannata, FG Klinger, C Di Bartolomeo, M Mattei, E Candi, M De Felici, G Melino and G Cesareni. (2009). Inhibition of the c-Abl-TAp63 pathway protects mouse oocytes from chemotherapyinduced death. Nat Med 15:1179-1185.
37. Tang YL, Y Tang, YC Zhang, K Qian, L Shen and MI Phillips. (2005). Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. J Am Coll Cardiol 46:1339-1350. (Pubitemid 41615559)
38. Mangi AA, N Noiseux, D Kong, H He, M Rezvani, JS Ingwall and VJ Dzau. (2003). Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 9:1195-1201. (Pubitemid 37173705)
39. Serakinci N, R Christensen, J Graakjaer, CJ Cairney, WN Keith, J Alsner, G Saretzki and S Kolvraa. (2007). Ectopically hTERT expressing adult human mesenchymal stem cells are less radiosensitive than their telomerase negative counterpart. Exp Cell Res 313:1056-1067. (Pubitemid 46273450)
40. Li W, N Ma, LL Ong, C Nesselmann, C Klopsch, Y Ladilov, D Furlani, C Piechaczek, JM Moebius, K Lutzow, A Lendlein, C Stamm, RK Li and G Steinhoff. (2007). Bcl-2 engineered MSCs inhibited apoptosis and improved heart function. Stem Cells 25:2118-2127. (Pubitemid 47258191)
41. Chen MF, CT Lin, WC Chen, CT Yang, CC Chen, SK Liao, JM Liu, CH Lu and KD Lee. (2006). The sensitivity of human mesenchymal stem cells to ionizing radiation. Int J Radiat Oncol Biol Phys 66:244-253. (Pubitemid 44175661)